Ameritas Investment Partners’s 1Life Healthcare ONEM Stock Holding History

Ameritas Investment Partners’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,139	Closed	-$229K	–	3040
2022 Q4	$229K	Hold	14,139	–	–	0.01%	1056
2022 Q3	$242K	Buy	14,139 +614	+5%	+$9.64K	0.01%	970
2022 Q2	$106K	Buy	13,525 +4,382	+48%	+$37.6K	﹤0.01%	1473
2022 Q1	$101K	Hold	9,143	–	–	﹤0.01%	1646
2021 Q4	$161K	Hold	9,143	–	–	0.01%	1376
2021 Q3	$185K	Hold	9,143	–	–	0.01%	1259
2021 Q2	$302K	Buy	9,143 +2,748	+43%	+$104K	0.01%	970
2021 Q1	$250K	Sell	6,395 -305	-5%	-$14.3K	0.01%	1069
2020 Q4	$292K	Hold	6,700	–	–	0.01%	941
2020 Q3	$190K	Buy	6,700 +5,030	+301%	+$159K	0.01%	1060
2020 Q2	$61K	Hold	1,670	–	–	﹤0.01%	1717
2020 Q1	$30K	Buy	+1,670	New	+$36.6K	﹤0.01%	1959

Ameritas Investment Partners's ONEM Position: Q1 2023 in Review

Ameritas Investment Partners sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 14,139 shares — an estimated $229K sold.

Ameritas Investment Partners first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $302K in Q2 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

Ameritas Investment Partners reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
Ameritas Investment Partners sold 14,139 1Life Healthcare shares in Q1 2023, an estimated $229K.
Ameritas Investment Partners first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
Ameritas Investment Partners's 1Life Healthcare position peaked at $302K in Q2 2021.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Ameritas Investment Partners's 13F filing for Q1 2023, filed 10 May 2023.